ERBB3 and breast cancer: In contrast, a study analyzing pathological tissue sections from BC patients revealed that high expression of NEDD4-1 is associated with elevated levels of cellular membrane-localized HER3 protein (Luhtala et al., 2018), suggesting that the degradation of HER3 by NEDD4-1 may be modulated by additional factors.